LightDark Log in Sign up

‹ Back to screener

ANTHEM.NS Anthem Biosciences Ltd.

Healthcare

Price history

1M 6M 1Y Max
2025-08-21 ₹846.35
2026-08-21 ₹875.85
Change over window +3.49%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 53.1%
Trailing 20-day average 56.1%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 375323 199117 53.05%
2026-08-27 1211725 645769 53.29%
2026-08-26 1851014 740175 39.99%
2026-08-25 317840 215987 67.95%
2026-08-24 730332 397238 54.39%
2026-08-21 781238 429831 55.02%
2026-08-20 286408 181140 63.25%
2026-08-19 304472 171986 56.49%
2026-08-18 477452 287522 60.22%
2026-08-17 693951 378870 54.60%
2026-08-14 390266 214419 54.94%
2026-08-13 446774 270246 60.49%
2026-08-12 425829 228771 53.72%
2026-08-11 1605598 608637 37.91%
2026-08-10 1250850 671843 53.71%
2026-08-07 472590 278709 58.97%
2026-08-06 799264 538690 67.40%
2026-08-05 332117 205754 61.95%
2026-08-04 832079 472275 56.76%
2026-08-03 960047 549598 57.25%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers ANTHEM.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
12 Mar 2026 Viridity Tone LLP Other Sell Market Sale 20313795 12552474510 0.18% XBRL
12 Mar 2026 Krithika Ganesh Promoter Group Sell Gift 8557302 0 0.00% XBRL
12 Mar 2026 Aruna Ganesh Promoter Group Buy Gift 8557302 0 3.05% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers ANTHEM.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹871.45 INR (live) · fetched 2026-08-23 21:34 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score

Ratios

P/E
82.72
P/E = Price / EPS
Source trace
P/E = Price / (ProfitLossForPeriod / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹871.45 / (₹5,917,920,000 / 561,715,000 shares) = ₹871.45 / ₹10.54 EPS
FY2025-26 · Annual filing
ROE
19.45%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitLossForPeriod / EquityAttributableToOwnersOfParent → ₹5,917,920,000 / ₹30,425,160,000 = 19.45%
FY2025-26 · Annual filing
Debt/Equity
0.02
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹510,680,000 / ₹30,425,160,000 = 0.02
FY2025-26 · Annual filing
Current Ratio
5.54
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹18,031,440,000 / ₹3,257,130,000 = 5.54
FY2025-26 · Annual filing
ROCE
27.65%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹8,555,240,000 / (₹30,425,160,000 + ₹510,680,000) = 27.65%
FY2025-26 · Annual filing
Dividend Yield
0.00%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹0 / 561,715,000 shares) / ₹871.45 = ₹0.00 / ₹871.45
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, —y actual) N/A
Net Profit (3y) N/A
Revenue (5y, —y actual) N/A
Net Profit (5y) N/A
Revenue (10y, —y actual) N/A
Net Profit (10y) N/A

Operating Margin Trend

FY2025-26 40.3%

Needs operating margin for 2+ stored years.

ROCE Trajectory

FY2025-26 27.7%

Earnings Quality

Needs net profit and CFO for 3+ stored years; only 0 on file.

Sector-Relative Percentile (Healthcare)

ROE 85th
ROCE 85th
Debt/Equity 70th
P/E 22th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹540.21 Cr. ₹550.03 Cr. ₹423.15 Cr. ₹610.94 Cr. ₹418.22 Cr. RevenueFromOperations
Net Profit ₹135.79 Cr. ₹173.43 Cr. ₹92.82 Cr. ₹189.76 Cr. ₹119.94 Cr. ProfitLossForPeriod

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers ANTHEM.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitLossForPeriod5917920000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital561715000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets18031440000.0
CurrentLiabilities3257130000.0
EquityAttributableToOwnersOfParent30425160000.0
BorrowingsCurrent + BorrowingsNoncurrent510680000.0

My notes